The ACR/ARHP Annual Meeting is the premier event for specialists in the field of rheumatology, and at this year’s meeting, basic researchers will be afforded multiple opportunities to increase their knowledge.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Bringing Fellows-in-Training to the Annual Meeting
The ACR supports fellows-in-training who wish to attend the ACR/ARHP Annual Meeting through the ACR Fellows Education Fund.
ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases
Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.
Pinpoint Cognitive Dysfunction in Patients with Lupus
More than 80% of SLE patients experience some type of neurologic manifestation during their disease course. The challenge for rheumatologists and other clinicians lies in appropriately diagnosing any cognitive dysfunctions that accompany lupus and better understanding the causes and risk factors of those dysfunctions. “Cognitive Function in SLE” was the focus of a talk at the 2011 ACR/ARHP Annual Scientific Meeting in November.
First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More
“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
Biosimilar Drugs Face Challenges to Reach the U.S. Market
To date, the FDA has not approved a biosimilar product. In its own discussion of the merits and obstacles to biosimilar drugs, the ACR sponsored a panel session titled, “Biosimilar Products in the U.S. Market: Fact or Fiction?” at the 2011 ACR/ARHP Annual Scientific Meeting here in November.
Where Will Kinase Inhibitors Fit into the RA Treatment Mix?
Presenters at “Looking Ahead to Kinase Inhibition in Rheumatoid Arthritis,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting, delved into some of the big questions that rheumatology faces with kinase inhibitor use.
Link between Autoimmunity and Environmental Exposure Needs Further Research
Rheumatology needs further cost-effective and validated methods to track the connection between environmental exposure and autoimmune diseases, including research on phenotypes, genotypes, the synergy between multiple infectious and noninfectious exposures, the timing of exposure, and the mechanisms involved, according to presenters of “Impact of Environmental Health on Autoimmunity,” a session here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.
ACR Volunteers Attend Leadership Development Conference
Last month, volunteers from the ACR, ARHP, and REF met in Atlanta for the Annual Leadership Development Conference. This year’s conference focused on media relations and social media in a healthcare environment. The goal of this year’s conference was to educate the volunteers on how to successfully use the different types of media outreach. The topics were timely, what with the launch of the ACR’s first public relations campaign, Simple Tasks, and a successful social media session held at the 2011 ACR/ARHP Annual Scientific Meeting.
- « Previous Page
- 1
- …
- 83
- 84
- 85
- 86
- 87
- …
- 91
- Next Page »